Clinical Trials
9 trialsNCT07235280 2026-02-19
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05493566 2026-02-12
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Emory University
Phase EARLY_PHASE1 Recruiting
NCT05620342 2026-02-05
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07236177 2026-02-05
B-GLUCANCER2
Poitiers University Hospital
Phase EARLY_PHASE1 Recruiting
NCT06645808 2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1 Recruiting
NCT06712745 2025-11-10
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Recruiting
NCT05543954 2024-07-05
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting
NCT06329908 2024-03-26
DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
Sichuan University
Phase EARLY_PHASE1 Recruiting
NCT05961111 2023-07-27
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Recruiting